Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells.
Chan Ra et al. (2011)
Keywords: Autologous adipose mesenchymal stem cells, autoimmune diseases, systemic stem cell infusion
This study looks at human adipose derived mesenchymal stem cells (hAdMSC’s) used for autoimmune diseases such as rheumatoid arthritis, polymyositis and autoimmune ear disease). The results showed therapeutic benefits for all patients, including long term benefits. Vitally, no adverse effects were shown. The study suggests it is clinically safe for multiple stem cell treatments within a month. Furthermore, no effect of donor-age dependent efficacy was shown, meaning a larger scope of patients may be suitable for the treatment.
Support available at Surecell
Our Surecell doctors are musculoskeletal experts who provide regenerative medicine treatments for osteoarthritis, such as platelet-rich plasma (PRP). Feel free to contact our friendly staff on 03 9822 9996 or submit an enquiry here.
Learn more about the treatments Surecell has to offer on our Services page.